The Value of Transvaginal Ultrasonography in the Endometrial Evaluation of Breast Cancer Patients Using Tamoxifen

By  

Medical Principles and Practice, Vol. 19, Iss. 3, 2010-03 ,pp. : 222-227

Karger

Access to resources Recommend Favorite

Ovarian cysts during tamoxifen use may affect the prognostic markers of premenopausal breast cancer

By Han Wonshik   Kim Hoon   Ku Seung-Yup   Kim Seok Hyun   Choi Young Min   Kim Jung Gu   Moon Shin Yong  

Gynecological Endocrinology, Vol. 29, Iss. 1, 2013-01 ,pp. : 16-19

Informa Healthcare

Access to resources Recommend Favorite

Black cohosh (Cimicifuga racemosa) in tamoxifen-treated breast cancer patients with climacteric complaints – a prospective observational study

By Rostock Matthias   Fischer Julia   Mumm Andreas   Stammwitz Ute   Saller Reinhard   Bartsch Hans Helge  

Gynecological Endocrinology, Vol. 27, Iss. 10, 2011-10 ,pp. : 844-848

Informa Healthcare

Access to resources Recommend Favorite

Fertility preservation in breast cancer patients: IVF and embryo cryopreservation after ovarian stimulation with tamoxifen

By Oktay K.   Buyuk E.   Davis O.   Yermakova I.   Veeck L.   Rosenwaks Z.  

Human Reproduction, Vol. 18, Iss. 1, 2003-01 ,pp. : 90-95

Oxford University Press

Access to resources Recommend Favorite

PT G20210A, factors V G1691A and 1299 His-Arg mutations and tamoxifen-associated thromboembolism in patients with breast cancer

By Eroglu A.   Cam R.   Yildiz Z.   Akar N.  

Thrombosis Research, Vol. 111, Iss. 4, 2003-01 ,pp. : 317-319

Elsevier

Access to resources Recommend Favorite